Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | PLAU | P00749 | 1/20 | 0.41 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 4/20 | 0.36 |
| ▸ | HTR2A | P28223 | 3/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | THRA | P10827 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 2/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20516081 | 0.96 | F2 (0.44) | F2PLAUST14HTR2CHTR2A | |
| SCHEMBL15065521 | 0.94 | CYP1A2 (0.39) | F2PLAUST14HTR2CHTR2A | |
| SCHEMBL19382957 | 0.93 | F2 (0.37) | F2PLAUST14HTR2CHTR2A | |
| SCHEMBL725616 | 0.89 | S1PR4 (0.40) | HTR2CHTR2B | |
| SCHEMBL15847648 | 0.89 | F2 (0.37) | F2PLAUST14HTR2CHTR2A | |
| SCHEMBL29066374 | 0.89 | CYP1A2 (0.44) | F2PLAUST14HTR2CHTR2A | |
| SCHEMBL23537567 | 0.87 | F2 (0.42) | F2PLAUST14HTR2CHTR2A | |
| SCHEMBL29913690 | 0.87 | F2 (0.42) | F2PLAUST14HTR2CHTR2A | |
| SCHEMBL16333705 | 0.87 | F2 (0.34) | F2PLAUST14HTR2CHTR2A | |
| SCHEMBL17861666 | 0.86 | PKM (0.37) | F2PLAUST14HTR2CHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565508-B2 | Group III and lanthanide bis-phenyl-phenoxy metal-ligand complexes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-03-03 | — | — | US | disclosed |
| EP-3925989-B1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-07 | — | — | EP | disclosed |
| US-12497414-B2 | Group III and Lanthanide bis-phenyl-phenoxy metal-ligand complexes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-12-16 | — | — | US | disclosed |
| EP-4097151-B1 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-115298227-B | Group III and lanthanide bis-phenyl-phenoxy metal-ligand complexes | 陶氏环球技术有限责任公司 | 2024-06-04 | — | — | CN | disclosed |
| EP-4332133-A2 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | Dow Global Technologies LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| CN-111491942-B | Metal-ligand complex, catalyst composition, and method for producing same | 沙特基础工业爱思开NEXLENE私人有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-117069749-A | Group III and lanthanide bis-phenyl-phenoxy metal-ligand complexes | 陶氏环球技术有限责任公司 | 2023-11-17 | — | — | CN | disclosed |
| US-20230183267-A1 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-15 | — | — | US | disclosed |
| US-20230183267-A1 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-15 | — | — | US | disclosed |
| US-9029487-B2 | Process for polymerizing a polymerizable olefin and catalyst therefor | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-05-12 | — | — | US | disclosed |
| US-9029487-B2 | Process for polymerizing a polymerizable olefin and catalyst therefor | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-05-12 | — | — | US | disclosed |
| WO-2014210333-A1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-12-31 | — | — | WO | disclosed |
| WO-2014210333-A1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-12-31 | — | — | WO | disclosed |
| EP-2609123-A1 | PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR | Dow Global Technologies LLC (US) | 2013-07-03 | — | — | EP | disclosed |
| US-20130144018-A1 | PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-06 | — | — | US | disclosed |
| US-20130144018-A1 | PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-06 | — | — | US | disclosed |
| US-20130144018-A1 | PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-06 | — | — | US | disclosed |
| WO-2012027448-A1 | PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-03-01 | — | — | WO | disclosed |
| WO-2012027448-A1 | PROCESS FOR POLYMERIZING A POLYMERIZABLE OLEFIN AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565508-B2 | Group III and lanthanide bis-phenyl-phenoxy metal-ligand complexes | SCO2, CBR3, SOD1 | F2 3337/4885PLAU 4205/4885ST14 3006/4885 |
| US-12497414-B2 | Group III and Lanthanide bis-phenyl-phenoxy metal-ligand complexes | SSB, SOD1, LGALS3 | F2 1069/4885PLAU 1824/4885ST14 2150/4885 |
| US-20230183267-A1 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | SSB, SOD1, LGALS3 | F2 953/4885PLAU 1783/4885ST14 2219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.